Smartphone app for atrial fibrillation and weight management
Part of Heart & circulation clinical trials.
This study uses a smartphone app and activity tracker to help people with atrial fibrillation (an irregular heartbeat) and a higher body weight manage their condition through tailored exercise guidance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have paroxysmal (lasts less than 7 days) or persistent (lasts 7 days or longer) atrial fibrillation
- Your body mass index (BMI) is 27 or higher
- You do not have permanent atrial fibrillation, severe valve disease, or a heart device
- You have not had heart surgery or cardiac arrest in the past
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a Fitbit activity tracker and a supportive exercise program helps people with AFib become more active. It may help you feel better and manage your heart rhythm.
This trial tests whether apixaban, a blood thinner, works well for people with atrial fibrillation who also have heart or circulation conditions. It uses a smartphone app to help track your treatment.
This study tests a mobile education program for people with atrial fibrillation. If you have an Android smartphone and meet the other criteria, you may be able to join and learn how to manage your condition better.
This trial uses a smartphone and smartwatch to track your atrial fibrillation over time. It aims to understand how the condition progresses and the risk of blood clots.
This study tests whether a program of exercise and healthy eating changes can reduce how often atrial fibrillation (AFib) happens and help you lose weight. It may be a good fit if you are overweight, have AFib, and are ready to make lifestyle changes.
This study tests whether using a smart watch to track your heart rhythm and guide treatment decisions can help manage paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes). Researchers will monitor your heart activity continuously through wearable devices to see if this approach improves outcomes.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.